Equine Endocrinology Summit Presentation and Resources
Following the 2011 Equine Endocrinology Summit, a subgroup of attendees formed a working group to provide guidance to help practitioners diagnose pituitary pars intermedia dysfunction (PPID) in their patients. The clinicians included:
- Nicholas Frank, DVM, PhD, DACVIM
- Frank Andrews, DVM, MS, DACVIM
- Ben Buchanan, DVM, DACVIM, DACVECC
- Andy Durham, BSc, BVSc, CertEP, DECEIM, MRCVS
- Janice Kritchevsky, VMD, MS, DACVIM
- Dianne McFarlane, DVM, PhD, DACVIM
- Hal Schott, DVM, PhD, DACVIM
As a result of their meeting, the following PPID diagnosis and treatment tools are now available to all veterinarians.
Click on the thumbnails below to view the working group recommendations.
Diagnosis and Treatment of PPID
PPID Diagnosis Sheet
2011 Equine Endocrinology Summit Highlights
About the Summit
Attendees at the 2011 Summit in Charlestown, SC, reviewed the latest developments related to pituitary pars intermedia dysfunction (PPID) and participated in roundtable discussions to identify areas where further research about the disease is needed.
The information and discussion shared at the Summit will aid researchers in developing diagnostic testing recommendations for PPID and characterizing its stages in affected horses.
Below are videos of the keynote lectures, as well as abstracts of some of the presentations.
Keynote lecture videos
Pathophysiology of Pituitary Pars Intermedia Dysfunction in 2011
Dianne McFarlane, DVM, PhD, Dipl. ACVIM
Associate Professor of Physiological Sciences
Oklahoma State University Center for Veterinary Health Sciences
Diagnosis of Pituitary Pars Intermedia Dysfunction in 2011
Jill Beech, DVM, Dipl. ACVIM
Georgia E. and Philip B. Hofmann Professor of Medicine and Reproduction
New Bolton Center, University of Pennsylvania School of Veterinary Medicine
General session presentations
Click on a title below to access an abstract of the presentation.
- Durham AE. Investigation of the in vitro stability of ACTH in horses.
- Codero M. Bioactivity of plasma ACTH from PPID-affected horses compared to normal horses.
- Paradis M. Comparison of MSH & ACTH levels in 179 horses in New England.
- Beech J. Comparison of cortisol and ACTH responses after administration of thyrotropin-releasing hormone (TRH) in normal horses and those with pituitary pars intermedia dysfunction (PPID).
- van der Kolk JH. Basal ACTH concentration in pituitary venous effluent and in response to diagnostic tests in 19-year-old warmblood gelding suffering from pituitary pars intermedia dysfunction.
- Durham AE. Investigation of inter-relationships between signalment and blood test results in 744 horses and ponies with pituitary pars intermedia dysfunction.
- van der Kolk JH. Glucose metabolism and peripheral insulin sensitivity in spontaneous equine pituitary pars intermedia dysfunction.
- Geor RJ. Age and diet affect glycemic and insulinemic responses of horses to a concentrate meal.
- Andrews FM. Diagnostic frequency, response to therapy and long-term prognosis among horses with equine Cushing’s disease, 1993–2004.
- Menzies-Gow NJ. Validation of a commercially available radioimmunoassay and species-specific ELISAs to measure high concentrations of insulin in equine serum.
- Wooldridge AA. High molecular weight adiponectin in horses.
- Refsal KR. Clinical survey of ionized calcium and whole-molecule parathyroid hormone results in horses.
- Kritchevsky J. Serum thyroxine concentrations in post-racing samples from Standardbred horses racing at an Indiana pari-mutual racetrack.
- Hart KA. Effects of low-dose hydrocortisone therapy on immune function in neonatal horses.
- Toribio RE. Somatotropic axis and growth hormone resistance in critically ill foals.
2011 SUMMIT PHOTOS
Click photo to enlarge.
Would you like to learn more about the Equine Endocrinology Summit?
